Skip to main content
Equibles

STATE STREET CORP

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 93751 BOSTON, MA
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$27,856
-$41,178 QoQ
Shares Held
121,114
0.0% QoQ
Ownership
0.273%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 48 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 73% Shared 0% None 27%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. VTGN ranks #391 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in VTGN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,856 121,114
2026-03-31 $69,034 121,114
2025-12-31 $79,935 121,114
2025-09-30 $343,845 96,858
2025-06-30 $193,716 96,858
2025-03-31 $242,145 96,858
2024-12-31 $285,731 96,858
2024-09-30 $267,011 88,708
2024-06-30 $308,703 88,708
2024-03-31 $441,978 83,708
2023-12-31 $254,471 49,508
2023-09-30 $133,431 25,464
2023-06-30 $47,617 25,464
2023-03-31 $771,842 6,432,023
2022-12-31 $616,277 6,162,771
2022-09-30 $844,809 5,632,066
2022-06-30 $3,427,950 3,895,398
2022-03-31 $4,476,201 3,609,840
2021-12-31 $16,770,456 8,600,234
2021-09-30 $21,523,080 7,855,139
2021-06-30 $9,637,771 3,059,610